H World Group Posts Upbeat Q3 Earnings, Joins CG Oncology, TELUS And Other Big Stocks Moving Higher On Monday
U.S. stocks fell, but H World Group surged 9.3% on strong Q3 results and raised guidance; several other stocks posted notable gains.
Last updated: 2026-11-16 22:53:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Fennec Pharmaceuticals Inc. (FENC) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $12.80, with a market capitalization of $410.25M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.65 to $13.25. This page covers its latest market performance, valuation, price trends and company information.
$410.25M | |
$11.92 | |
$12.87 | |
$11.39 | |
$11.62 | |
745.24K | |
186.33K | |
-- | |
$13.25 | |
$5.65 | |
-- | |
-- |
Fennec Pharmaceuticals Inc. (FENC) is trading at $12.01 in after-hours trading as of 2026-11-16 22:16:00, down 6.16% ($0.79) from the regular-session close of $12.80.
After-hours trading shows how investors are pricing FENC after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
FENC is down 5.62% in after-hours trading.
Over the past seven days, Fennec Pharmaceuticals Inc. (FENC) moved from $9.39 to $12.80, representing a gain of 36.29% ($3.41).
The stock traded between $9.20 and $12.87 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 254.99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 94.1%
FENC is currently trading at $12.80, placing it 94.1% of the way from its 52-week low of $5.65 to its 52-week high of $13.25. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
| Industry | BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) |
| Employees | 35 |
| Exchange | NASDAQ |
| Company Website |
Latest news related to Fennec Pharmaceuticals Inc. and FENC stock.
U.S. stocks fell, but H World Group surged 9.3% on strong Q3 results and raised guidance; several other stocks posted notable gains.
B. Riley Securities analyst Madison El-Saadi reiterates Fennec Pharmaceuticals (NASDAQ:FENC) with a Buy and raises the price target from $18 to $19.
Fennec Pharmaceuticals (NASDAQ:FENC) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by
Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.10 by 20 percent. This is a 700 percent increase over losses of $(0.02) per share from
Eligible investors can buy real shares of Fennec Pharmaceuticals Inc. (FENC) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to FENC, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between FENC shares and USD.
FENC Shares to USD
1.00 FENC shares = 12.798 USD
Calculations are estimates based on the latest available price and are for reference only.